Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK at 30 months of follow-up.

dc.contributor.author	Mandel, Nil Molinas
dc.contributor.author	Ozdogan, Mustafa
dc.contributor.author	Buyukberber, Suleyman
dc.contributor.author	Demir, Gokhan
dc.contributor.author	Gokmen, Erhan
dc.contributor.author	Akbulut, Hakan
dc.contributor.author	Paydas, Semra
dc.contributor.author	Celik, Ismail
dc.contributor.author	Sevinc, Alper
dc.contributor.author	Turna, Hande
dc.date.accessioned	2021-03-03T10:54:45Z
dc.date.available	2021-03-03T10:54:45Z
dc.identifier.citation	Sevinc A., Turna H., Ozdogan M., Buyukberber S., Demir G., Gokmen E., Mandel N. M. , Paydas S., Akbulut H., Celik I., "Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK at 30 months of follow-up.", 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31
dc.identifier.other	av_254430dd-8d56-4441-9141-eb829acf52fa
dc.identifier.other	vv_1032021
dc.identifier.uri	http://hdl.handle.net/20.500.12627/29948
dc.language.iso	eng
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Tıp
dc.subject	ONKOLOJİ
dc.title	Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK at 30 months of follow-up.
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	31
dc.contributor.firstauthorID	141573

Files in this item

Files	Size	Format	View
There are no files associated with this item.